Jeffrey Kaplan
Concepts (281)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biofilms | 27 | 2016 | 236 | 6.250 |
Why?
| Staphylococcus epidermidis | 12 | 2018 | 70 | 2.670 |
Why?
| Polysaccharides, Bacterial | 11 | 2015 | 68 | 2.120 |
Why?
| Aggregatibacter actinomycetemcomitans | 14 | 2015 | 19 | 2.110 |
Why?
| Staphylococcus aureus | 7 | 2018 | 400 | 1.970 |
Why?
| Actinobacillus pleuropneumoniae | 5 | 2013 | 5 | 1.640 |
Why?
| Anti-Bacterial Agents | 12 | 2018 | 1562 | 1.560 |
Why?
| Bacterial Adhesion | 13 | 2018 | 79 | 1.540 |
Why?
| DNA, Bacterial | 6 | 2012 | 324 | 1.260 |
Why?
| Adhesins, Bacterial | 6 | 2010 | 38 | 0.890 |
Why?
| Bacterial Proteins | 14 | 2014 | 775 | 0.890 |
Why?
| Prosthesis-Related Infections | 4 | 2011 | 74 | 0.880 |
Why?
| Actinobacillus Infections | 5 | 2008 | 5 | 0.850 |
Why?
| Kingella kingae | 2 | 2012 | 8 | 0.830 |
Why?
| Extracellular Space | 2 | 2012 | 132 | 0.800 |
Why?
| Povidone-Iodine | 2 | 2018 | 11 | 0.760 |
Why?
| Deoxyribonuclease I | 4 | 2018 | 36 | 0.750 |
Why?
| Acetylglucosamine | 4 | 2008 | 10 | 0.720 |
Why?
| Staphylococcal Skin Infections | 1 | 2018 | 30 | 0.660 |
Why?
| Cetylpyridinium | 4 | 2009 | 6 | 0.590 |
Why?
| Microbial Sensitivity Tests | 6 | 2016 | 312 | 0.590 |
Why?
| Amoxicillin | 1 | 2016 | 19 | 0.570 |
Why?
| beta-Lactams | 2 | 2016 | 29 | 0.570 |
Why?
| Glycoside Hydrolases | 7 | 2012 | 31 | 0.550 |
Why?
| Pasteurellaceae | 3 | 2010 | 3 | 0.500 |
Why?
| Genome, Bacterial | 2 | 2012 | 111 | 0.490 |
Why?
| Exotoxins | 3 | 2008 | 15 | 0.470 |
Why?
| Bacterial Capsules | 1 | 2013 | 29 | 0.460 |
Why?
| Molecular Sequence Data | 12 | 2012 | 2933 | 0.450 |
Why?
| Neisseriaceae Infections | 1 | 2012 | 5 | 0.440 |
Why?
| Arthritis, Infectious | 1 | 2012 | 52 | 0.410 |
Why?
| Drug Resistance, Bacterial | 4 | 2018 | 163 | 0.400 |
Why?
| Extracellular Matrix | 2 | 2014 | 461 | 0.390 |
Why?
| Recombination, Genetic | 1 | 2011 | 175 | 0.390 |
Why?
| Enzyme Therapy | 1 | 2009 | 5 | 0.360 |
Why?
| beta-Glucans | 1 | 2008 | 19 | 0.340 |
Why?
| Haemophilus influenzae | 1 | 2009 | 51 | 0.340 |
Why?
| Disinfectants | 1 | 2009 | 35 | 0.340 |
Why?
| Mouth Mucosa | 2 | 2007 | 81 | 0.330 |
Why?
| Down-Regulation | 1 | 2011 | 654 | 0.330 |
Why?
| Polysaccharides | 1 | 2008 | 81 | 0.320 |
Why?
| Virulence Factors | 2 | 2008 | 143 | 0.310 |
Why?
| Galactans | 1 | 2007 | 4 | 0.300 |
Why?
| Genes, Bacterial | 2 | 2004 | 165 | 0.300 |
Why?
| Drug Resistance | 1 | 2007 | 169 | 0.280 |
Why?
| Aggressive Periodontitis | 2 | 2003 | 3 | 0.280 |
Why?
| Swine Diseases | 1 | 2005 | 11 | 0.270 |
Why?
| Bacteria | 2 | 2012 | 772 | 0.240 |
Why?
| Acetylglucosaminidase | 1 | 2003 | 5 | 0.240 |
Why?
| Sequence Analysis, DNA | 4 | 2009 | 766 | 0.210 |
Why?
| Bacterial Physiological Phenomena | 2 | 2014 | 57 | 0.210 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 2 | 2016 | 194 | 0.210 |
Why?
| Recombinant Proteins | 4 | 2018 | 1318 | 0.200 |
Why?
| Macrophages | 1 | 2008 | 1334 | 0.200 |
Why?
| Polymerase Chain Reaction | 5 | 2008 | 1021 | 0.190 |
Why?
| Barrett Esophagus | 1 | 2023 | 159 | 0.190 |
Why?
| Osteopontin | 1 | 2020 | 39 | 0.190 |
Why?
| Chemokine CXCL10 | 1 | 2020 | 40 | 0.190 |
Why?
| Gastroesophageal Reflux | 1 | 2023 | 252 | 0.190 |
Why?
| Microfluidics | 2 | 2010 | 52 | 0.180 |
Why?
| Animals | 15 | 2018 | 34133 | 0.180 |
Why?
| Polystyrenes | 3 | 2004 | 35 | 0.180 |
Why?
| Esophageal Neoplasms | 1 | 2023 | 287 | 0.180 |
Why?
| Humans | 30 | 2023 | 122796 | 0.170 |
Why?
| Microfluidic Analytical Techniques | 2 | 2010 | 74 | 0.170 |
Why?
| Sus scrofa | 1 | 2018 | 57 | 0.170 |
Why?
| Species Specificity | 3 | 2011 | 578 | 0.160 |
Why?
| Cystadenoma, Serous | 1 | 2018 | 19 | 0.160 |
Why?
| Carcinoma, Hepatocellular | 1 | 2019 | 231 | 0.160 |
Why?
| Liver | 2 | 2020 | 1827 | 0.160 |
Why?
| Epithelial Cells | 3 | 2010 | 995 | 0.150 |
Why?
| Pancreatic Cyst | 1 | 2018 | 49 | 0.150 |
Why?
| Base Sequence | 4 | 2012 | 2186 | 0.150 |
Why?
| Neuroendocrine Tumors | 1 | 2018 | 91 | 0.150 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 284 | 0.150 |
Why?
| Mutagenesis, Insertional | 3 | 2008 | 62 | 0.130 |
Why?
| Staphylococcal Infections | 2 | 2012 | 348 | 0.130 |
Why?
| Pasteurellaceae Infections | 1 | 2015 | 1 | 0.130 |
Why?
| Liver Neoplasms | 1 | 2019 | 546 | 0.130 |
Why?
| Escherichia coli | 3 | 2010 | 767 | 0.130 |
Why?
| DNA Transposable Elements | 3 | 2008 | 102 | 0.130 |
Why?
| Acinetobacter baumannii | 1 | 2014 | 16 | 0.130 |
Why?
| Magnetic Resonance Spectroscopy | 2 | 2007 | 513 | 0.130 |
Why?
| Mouth | 1 | 2015 | 81 | 0.130 |
Why?
| Periodontal Diseases | 1 | 2015 | 58 | 0.130 |
Why?
| Air | 1 | 2014 | 50 | 0.120 |
Why?
| Bone Resorption | 1 | 2015 | 80 | 0.120 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 90 | 0.120 |
Why?
| Anilides | 1 | 2014 | 69 | 0.120 |
Why?
| Plankton | 1 | 2014 | 5 | 0.120 |
Why?
| Proto-Oncogene Proteins c-met | 1 | 2014 | 70 | 0.120 |
Why?
| Biopsy | 1 | 2018 | 1090 | 0.120 |
Why?
| Dose-Response Relationship, Drug | 2 | 2011 | 1981 | 0.120 |
Why?
| Molecular Weight | 1 | 2013 | 346 | 0.110 |
Why?
| Disease Models, Animal | 3 | 2018 | 3799 | 0.110 |
Why?
| Coated Materials, Biocompatible | 1 | 2012 | 60 | 0.110 |
Why?
| Tobramycin | 1 | 2011 | 48 | 0.100 |
Why?
| Cell Survival | 3 | 2012 | 1075 | 0.100 |
Why?
| Cell Communication | 1 | 2013 | 287 | 0.100 |
Why?
| Genetic Complementation Test | 2 | 2008 | 62 | 0.100 |
Why?
| Culture Media | 3 | 2010 | 165 | 0.100 |
Why?
| Pyridines | 1 | 2014 | 440 | 0.100 |
Why?
| Orthopedic Equipment | 1 | 2010 | 6 | 0.100 |
Why?
| Treatment Failure | 1 | 2011 | 348 | 0.090 |
Why?
| Focal Nodular Hyperplasia | 1 | 2010 | 2 | 0.090 |
Why?
| Pancreatic Neoplasms | 1 | 2018 | 803 | 0.090 |
Why?
| Fungi | 1 | 2011 | 125 | 0.090 |
Why?
| Escherichia coli Proteins | 1 | 2011 | 180 | 0.090 |
Why?
| Titanium | 1 | 2010 | 64 | 0.090 |
Why?
| Bacterial Outer Membrane Proteins | 2 | 2007 | 58 | 0.090 |
Why?
| Mutation | 5 | 2009 | 3493 | 0.090 |
Why?
| DNA Primers | 2 | 2007 | 540 | 0.090 |
Why?
| Osteoblasts | 1 | 2010 | 119 | 0.090 |
Why?
| Sodium Hypochlorite | 1 | 2009 | 4 | 0.090 |
Why?
| Sodium Dodecyl Sulfate | 1 | 2009 | 21 | 0.090 |
Why?
| Convection | 1 | 2008 | 7 | 0.090 |
Why?
| Prostheses and Implants | 1 | 2010 | 145 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2011 | 291 | 0.090 |
Why?
| Enzymes | 1 | 2009 | 66 | 0.090 |
Why?
| Chlorhexidine | 1 | 2009 | 22 | 0.090 |
Why?
| Azo Compounds | 1 | 2008 | 26 | 0.090 |
Why?
| Colony Count, Microbial | 1 | 2009 | 124 | 0.080 |
Why?
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2008 | 4 | 0.080 |
Why?
| Diffusion | 1 | 2008 | 127 | 0.080 |
Why?
| Caenorhabditis elegans | 1 | 2011 | 289 | 0.080 |
Why?
| Periodontitis | 2 | 2006 | 42 | 0.080 |
Why?
| beta-N-Acetylhexosaminidases | 1 | 2007 | 11 | 0.080 |
Why?
| Congo Red | 1 | 2007 | 9 | 0.080 |
Why?
| Gene Order | 1 | 2007 | 29 | 0.080 |
Why?
| Tritium | 1 | 2007 | 71 | 0.080 |
Why?
| Detergents | 1 | 2007 | 46 | 0.080 |
Why?
| Colorectal Neoplasms | 1 | 2014 | 646 | 0.080 |
Why?
| Chromosomes, Bacterial | 1 | 2007 | 7 | 0.080 |
Why?
| Ampicillin | 1 | 2007 | 15 | 0.080 |
Why?
| Glycosyltransferases | 1 | 2007 | 13 | 0.080 |
Why?
| Glycogen Storage Disease Type IV | 1 | 2006 | 4 | 0.070 |
Why?
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 4 | 0.070 |
Why?
| Amino Acid Sequence | 3 | 2008 | 2123 | 0.070 |
Why?
| Cell Line, Tumor | 2 | 2014 | 2904 | 0.070 |
Why?
| Hydrogels | 2 | 2012 | 596 | 0.070 |
Why?
| Pleuropneumonia | 1 | 2005 | 1 | 0.070 |
Why?
| Gene Deletion | 1 | 2007 | 365 | 0.070 |
Why?
| Female | 8 | 2020 | 63629 | 0.070 |
Why?
| Surface Properties | 3 | 2012 | 402 | 0.060 |
Why?
| Prenatal Diagnosis | 1 | 2006 | 171 | 0.060 |
Why?
| Carbohydrate Metabolism | 1 | 2004 | 50 | 0.060 |
Why?
| Male | 9 | 2020 | 59639 | 0.060 |
Why?
| Primates | 1 | 2005 | 114 | 0.060 |
Why?
| Lactoferrin | 1 | 2003 | 30 | 0.060 |
Why?
| Polyethylene Glycols | 1 | 2008 | 560 | 0.060 |
Why?
| Catheterization | 1 | 2004 | 165 | 0.060 |
Why?
| Metaplasia | 1 | 2023 | 59 | 0.060 |
Why?
| O Antigens | 1 | 2003 | 9 | 0.060 |
Why?
| Antineoplastic Agents | 1 | 2014 | 1990 | 0.060 |
Why?
| Middle Aged | 6 | 2020 | 28563 | 0.060 |
Why?
| Bacteriological Techniques | 1 | 2003 | 67 | 0.060 |
Why?
| Serotyping | 1 | 2002 | 33 | 0.050 |
Why?
| Microscopy, Electron | 1 | 2003 | 418 | 0.050 |
Why?
| Promoter Regions, Genetic | 2 | 2009 | 1188 | 0.050 |
Why?
| Swine | 1 | 2005 | 777 | 0.050 |
Why?
| DNA, Ribosomal | 1 | 2002 | 82 | 0.050 |
Why?
| Liver Transplantation | 1 | 2010 | 929 | 0.050 |
Why?
| Esophagoscopy | 1 | 2023 | 191 | 0.050 |
Why?
| Transcriptional Activation | 1 | 2003 | 360 | 0.050 |
Why?
| Adult | 6 | 2020 | 32385 | 0.050 |
Why?
| Bacterial Toxins | 1 | 2002 | 107 | 0.050 |
Why?
| Mice | 4 | 2014 | 15888 | 0.050 |
Why?
| Phenotype | 2 | 2010 | 3070 | 0.050 |
Why?
| Kinetics | 1 | 2004 | 1658 | 0.050 |
Why?
| Models, Biological | 1 | 2007 | 1756 | 0.050 |
Why?
| Coculture Techniques | 2 | 2010 | 213 | 0.050 |
Why?
| RNA, Ribosomal, 16S | 1 | 2002 | 535 | 0.040 |
Why?
| Transcription, Genetic | 2 | 2020 | 1355 | 0.040 |
Why?
| ROC Curve | 1 | 2020 | 494 | 0.040 |
Why?
| Postoperative Complications | 1 | 2010 | 2301 | 0.040 |
Why?
| Infant | 1 | 2012 | 8523 | 0.040 |
Why?
| Phylogeny | 1 | 2002 | 830 | 0.040 |
Why?
| Carcinoembryonic Antigen | 1 | 2018 | 40 | 0.040 |
Why?
| Cyst Fluid | 1 | 2018 | 28 | 0.040 |
Why?
| Surgical Instruments | 1 | 2018 | 51 | 0.040 |
Why?
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 57 | 0.040 |
Why?
| Neoplasm Recurrence, Local | 1 | 2023 | 903 | 0.040 |
Why?
| Aged, 80 and over | 2 | 2019 | 6845 | 0.040 |
Why?
| Genetic Variation | 1 | 2002 | 952 | 0.040 |
Why?
| Endosonography | 1 | 2018 | 148 | 0.040 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1003 | 0.040 |
Why?
| Binding Sites | 2 | 2010 | 1247 | 0.030 |
Why?
| Cell Line | 2 | 2012 | 2785 | 0.030 |
Why?
| Monosaccharides | 1 | 2014 | 9 | 0.030 |
Why?
| Feasibility Studies | 1 | 2018 | 780 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 2019 | 1855 | 0.030 |
Why?
| HCT116 Cells | 1 | 2014 | 71 | 0.030 |
Why?
| Aged | 3 | 2019 | 20495 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2015 | 2501 | 0.030 |
Why?
| Transcriptome | 1 | 2020 | 774 | 0.030 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 82 | 0.030 |
Why?
| Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 179 | 0.030 |
Why?
| Microscopy | 1 | 2014 | 132 | 0.030 |
Why?
| Disease Progression | 1 | 2020 | 2546 | 0.030 |
Why?
| Mice, Nude | 1 | 2014 | 668 | 0.030 |
Why?
| Angiogenesis Inhibitors | 1 | 2014 | 223 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3296 | 0.030 |
Why?
| Neovascularization, Pathologic | 1 | 2014 | 292 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 358 | 0.030 |
Why?
| Polymethacrylic Acids | 1 | 2012 | 61 | 0.030 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 433 | 0.030 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2014 | 747 | 0.030 |
Why?
| Gene Expression Profiling | 2 | 2009 | 1625 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2019 | 1519 | 0.030 |
Why?
| Rats | 2 | 2015 | 5426 | 0.030 |
Why?
| Propidium | 1 | 2010 | 4 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2020 | 2491 | 0.020 |
Why?
| 3T3 Cells | 1 | 2010 | 141 | 0.020 |
Why?
| Cell Shape | 1 | 2010 | 55 | 0.020 |
Why?
| Alloys | 1 | 2010 | 30 | 0.020 |
Why?
| Cohort Studies | 1 | 2020 | 5294 | 0.020 |
Why?
| Siphoviridae | 1 | 2009 | 2 | 0.020 |
Why?
| Bacteriophage T7 | 1 | 2009 | 3 | 0.020 |
Why?
| Artificial Gene Fusion | 1 | 2009 | 5 | 0.020 |
Why?
| Plasmids | 1 | 2010 | 358 | 0.020 |
Why?
| Nucleotides | 1 | 2009 | 114 | 0.020 |
Why?
| Protein Hydrolysates | 1 | 2008 | 7 | 0.020 |
Why?
| Caseins | 1 | 2008 | 22 | 0.020 |
Why?
| Buffers | 1 | 2008 | 56 | 0.020 |
Why?
| Genes, Reporter | 1 | 2009 | 274 | 0.020 |
Why?
| Lipopolysaccharides | 1 | 2012 | 875 | 0.020 |
Why?
| Cell Adhesion | 1 | 2010 | 454 | 0.020 |
Why?
| Adolescent | 2 | 2010 | 18948 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2010 | 418 | 0.020 |
Why?
| Microscopy, Electron, Scanning | 1 | 2008 | 201 | 0.020 |
Why?
| Time Factors | 2 | 2010 | 6682 | 0.020 |
Why?
| Rifampin | 1 | 2008 | 71 | 0.020 |
Why?
| Biomarkers, Tumor | 1 | 2014 | 1076 | 0.020 |
Why?
| Orthopedics | 1 | 2010 | 163 | 0.020 |
Why?
| Microscopy, Atomic Force | 1 | 2008 | 119 | 0.020 |
Why?
| Cercopithecidae | 1 | 2007 | 6 | 0.020 |
Why?
| Child | 2 | 2010 | 19561 | 0.020 |
Why?
| Sequence Alignment | 1 | 2008 | 343 | 0.020 |
Why?
| Sodium Chloride | 1 | 2008 | 154 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2009 | 402 | 0.020 |
Why?
| Phosphates | 1 | 2008 | 170 | 0.020 |
Why?
| Hydrolysis | 1 | 2007 | 189 | 0.020 |
Why?
| Cyclic AMP | 1 | 2008 | 260 | 0.020 |
Why?
| Hemolysis | 1 | 2008 | 167 | 0.020 |
Why?
| Drug Interactions | 1 | 2008 | 356 | 0.020 |
Why?
| Abortion, Eugenic | 1 | 2006 | 4 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2007 | 376 | 0.020 |
Why?
| Knee Prosthesis | 1 | 2006 | 16 | 0.020 |
Why?
| Substrate Specificity | 1 | 2007 | 375 | 0.020 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 511 | 0.020 |
Why?
| Hip Prosthesis | 1 | 2006 | 35 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 368 | 0.020 |
Why?
| Equipment Design | 1 | 2008 | 533 | 0.020 |
Why?
| Tissue Engineering | 1 | 2010 | 366 | 0.020 |
Why?
| Genome Components | 1 | 2006 | 2 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 2007 | 547 | 0.020 |
Why?
| Fimbriae, Bacterial | 1 | 2006 | 28 | 0.020 |
Why?
| Protein Transport | 1 | 2007 | 418 | 0.020 |
Why?
| Fatal Outcome | 1 | 2006 | 299 | 0.020 |
Why?
| Cell Differentiation | 1 | 2012 | 1805 | 0.020 |
Why?
| Membrane Transport Proteins | 1 | 2006 | 137 | 0.020 |
Why?
| Calcium | 1 | 2010 | 1244 | 0.020 |
Why?
| Spodoptera | 1 | 2003 | 39 | 0.020 |
Why?
| Computer Simulation | 1 | 2008 | 945 | 0.010 |
Why?
| Genetic Testing | 1 | 2006 | 400 | 0.010 |
Why?
| Alveolar Bone Loss | 1 | 2003 | 10 | 0.010 |
Why?
| Maxilla | 1 | 2003 | 29 | 0.010 |
Why?
| Cell Proliferation | 1 | 2010 | 2328 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2003 | 551 | 0.010 |
Why?
| Models, Molecular | 1 | 2007 | 1443 | 0.010 |
Why?
| Adenosine Triphosphatases | 1 | 2003 | 160 | 0.010 |
Why?
| Virulence | 1 | 2003 | 254 | 0.010 |
Why?
| Iron | 1 | 2003 | 239 | 0.010 |
Why?
| Signal Transduction | 1 | 2014 | 4902 | 0.010 |
Why?
| Polymorphism, Genetic | 1 | 2003 | 666 | 0.010 |
Why?
| DNA | 1 | 2006 | 1401 | 0.010 |
Why?
| Genotype | 1 | 2003 | 1943 | 0.010 |
Why?
| Child, Preschool | 1 | 2010 | 9755 | 0.010 |
Why?
| Infant, Newborn | 1 | 2006 | 5430 | 0.010 |
Why?
| Pregnancy | 1 | 2006 | 5854 | 0.010 |
Why?
| Cardiovascular Diseases | 1 | 2006 | 1859 | 0.010 |
Why?
|
|
Kaplan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|